Published in Life Sci on December 08, 1980
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol (2000) 1.66
Secretion of hydrolases by perfused fragments of rat pancreas: effect of calcium. Am J Physiol (1971) 1.62
Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology (1995) 1.44
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology (1995) 1.37
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res (2000) 1.29
Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol (1990) 1.28
Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology (1996) 1.26
In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. J Clin Invest (1976) 1.25
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
The stimulus-secretion coupling of glucose-induced insulin release. XLVI. Physiological role of L-glutamine as a fuel for pancreatic islets. Mol Cell Endocrinol (1980) 1.19
Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A (1994) 1.16
Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut (1998) 1.16
In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides (1997) 1.15
Purification and characterization of undegraded human ceruloplasmin. Anal Biochem (1980) 1.14
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem (2001) 1.14
Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes. Br J Pharmacol (1992) 1.14
In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. Gastroenterology (1975) 1.12
ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. Eur J Pharmacol (1992) 1.12
Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res (1995) 1.09
Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol Pharmacol (1982) 1.09
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor. Peptides (2000) 1.08
Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin. Proc Natl Acad Sci U S A (1978) 1.08
Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut (1995) 1.07
Pancreatic secretion of total protein and of three hydrolases collected in healthy subjects via duodenoscopic cannulation. Effects of secretin, pancreozymin, and caerulein. Gastroenterology (1975) 1.05
Development of high affinity selective VIP1 receptor agonists. Peptides (1997) 1.04
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides (1996) 1.04
Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett (1998) 1.04
Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Mol Cell Neurosci (2005) 1.03
Exocrine pancreas: evidence for topographic partition of secretory function. Science (1975) 1.03
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985) 1.03
Rat pancreatic hydrolases from birth to weaning and dietary adaptation after weaning. Am J Physiol (1971) 1.02
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol (1989) 1.01
The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic interaction of L-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta (1981) 1.00
Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site. Biochem J (1988) 0.99
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985) 0.99
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality. Peptides (1999) 0.99
In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'. FEBS Lett (1983) 0.99
Effect of a high-fat diet on obese-hyperglycaemic and non-obese Bar Harbor mice. Diabetologia (1971) 0.98
Factors regulating biosynthesis, intracellular transport and secretion of amylase and lipase in the rat exocrine pancreas. Horm Metab Res (1971) 0.98
The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol (1983) 0.97
Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun (1994) 0.97
Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril (1997) 0.96
Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom. FEBS Lett (1984) 0.95
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides (1997) 0.95
Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides (1984) 0.95
Effects of somatostatin on pancreatic exocrine function. Interaction with secretin. Biochem Biophys Res Commun (1975) 0.94
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett (1990) 0.94
Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol Pharmacol (1986) 0.94
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors. Eur J Pharmacol (1998) 0.93
Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. Receptors Channels (1999) 0.93
Helodermin has a VIP-like effect upon canine blood flow. Peptides (1986) 0.93
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands. Mol Pharmacol (1999) 0.93
In vivo effects of pancreozymin, secretin, vasoactive intestinal polypeptide and pilocarpine on the levels of cyclic AMP and cyclic GMP in the rat pancreas. FEBS Lett (1974) 0.93
A calcium-dependent protein activator of guanosine 3':5'-monophosphate phosphodiesterase in bovine and rat pancreas. Isolation, properties and levels in vivo. Eur J Biochem (1977) 0.93
Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands. Arch Oral Biol (1985) 0.93
Scorpion venom inhibits carbamylcholine-induced 86rubidium efflux from rat parotid acini. FEBS Lett (1987) 0.93
Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. Transplant Proc (1990) 0.93
RDC1 may not be VIP receptor. Trends Pharmacol Sci (1992) 0.92
Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom. FEBS Lett (1984) 0.92
Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem Soc Trans (2007) 0.92
80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors. FEBS Lett (1988) 0.92
[Lipid metabolism in livers of normal mice and obese hyperglycemic mice]. Biochim Biophys Acta (1968) 0.91
The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology (1999) 0.91
Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. Mol Pharmacol (1987) 0.90
Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides (1997) 0.90
Hormone-stimulated GTPase activity in rat pancreatic plasma membranes. FEBS Lett (1979) 0.90
The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. Mol Pharmacol (1983) 0.90
Mechanism of 3-phenylpyruvate-induced insulin release. Metabolic aspects. Biochem J (1983) 0.90
Characterization of muscarinic cholinergic receptors on rat pancreatic acini by N-[3H]methylscopolamine binding. Their relationship with calcium 45 efflux and amylase secretion. J Biol Chem (1984) 0.90